This defect is exacerbated by near-universal neutralizing autoantibodies to type I interferons (IFN-α and IFN-ω), which play a central role in tumor immune surveillance of tumors by activating dendritic cells and cytotoxic T lymphocytes and promoting tumor antigen presentation. Here, IFNA1 is linked to neoplasm.